Prioritized proteomic signatures

Prioritized proteomic signatures predict 5-year incident age-related macular degeneration risk in humans (AUC = 0.734).

“Utilizing these prioritized proteomic signatures, a LightGBM machine learning framework achieved robust predictive performance for 5-year incident risk (AUC = 0.734).”

HumansLightGBM prediction frameworkplasma5 yearsmales

Y-chromosome loss linked to later eye disease in men

Aging cell·Oct 1, 2026